A recent study purports to show that FDA warnings about the link between the use of anti-depressants and teen suicide may have led to more suicides. The NYT has an excellent article this morning pointing out that the evidence in the study is far from conclusive.
Assessing the evidence on such issues would be difficult for researchers and medical experts in any case, but the fact that an industry has billions of dollars at stake in pushing a particular position cannot help matters. The pharmaceutical industry has not hesitated to pay large sums to researchers to promote views that support its products. Unfortunately, this article does not mention the perverse incentive created by patent rents on this issue.
If you enjoyed this article, please consider making a tax-deductible donation today. For over 30 years, The American Prospect has delivered independent reporting that exposes corporate power, investigates political corruption, and analyzes threats to our democracy. Unlike many media outlets, we’re not owned by billionaires or corporations—we’re powered by readers like you.
Today’s independent journalism faces unprecedented challenges. Your support makes our reporting possible and keeps our work free and accessible to all. Whether it’s $5 or $50, every contribution helps sustain our nonprofit newsroom.
Join our community of supporters and make a donation today to help keep independent journalism thriving.
Copyright 2025 | The American Prospect, Inc. | All Rights Reserved
